Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DECK -12.5%, BAH -8.5%, NEM -6.4%, MHK -4.2%, MGRC -3.2%, KN -2.9%, COUR -2.5%, MRTN -2.2%, WSFS -2.1%, ASB -2%, BKR -1.9%, BYD -1.7%, SBSI -1.3%, ALK -1.2%, KNSL -1.1%, VRSN -1.1%, WKC -1%
Other news:
- COYA -12.5% (stock offering)
- COYA -12.5% (announces pricing of $20 million upsized public offering of common stock)
- ULH -5.5% (postpones Q3 earnings release)
- NEWP -5.4% (appoints CEO and CFO)
- GSK -4.5% (FDA approves Blenrep for multiple myeloma)
- XFOR -3.9% (prices offering consisting of common stock and warrants)
- NIC -3.2% (NIC to acquire MOFG, also reports earnings)
- VTOL -1.7% (files mixed securities shelf offering)
- NBTX -1.4% (updates JNJ-1900 (NBTXR3) clinical program following transfer of ongoing Phase 3 Head and Neck Cancer Trial sponsorship and operational control)
- UBS -1% (announces executive board and board of directors changes)